CLINICAL TRIALS PROFILE FOR GLIADEL
✉ Email this page to a colleague
All Clinical Trials for GLIADEL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003463 ↗ | Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas | Completed | National Cancer Institute (NCI) | Phase 1 | 1998-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of carmustine wafers plus irinotecan in treating patients with recurrent supratentorial high grade gliomas. |
| NCT00003463 ↗ | Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas | Completed | Duke University | Phase 1 | 1998-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of carmustine wafers plus irinotecan in treating patients with recurrent supratentorial high grade gliomas. |
| NCT00003467 ↗ | Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | Completed | National Cancer Institute (NCI) | Phase 2 | 1998-01-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carmustine in treating adults with recurrent supratentorial low-grade glioma. |
| NCT00003467 ↗ | Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | Completed | Duke University | Phase 2 | 1998-01-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carmustine in treating adults with recurrent supratentorial low-grade glioma. |
| NCT00003876 ↗ | Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma | Completed | Barrett Cancer Center | Phase 1 | 1999-04-01 | RATIONALE: Internal radiation uses high-energy radiation to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining internal radiation therapy with chemotherapy implants may kill remaining tumor cells following surgery. PURPOSE: Phase I trial to study the effectiveness of internal radiation therapy plus carmustine implants in treating patients who have recurrent or refractory malignant glioma. |
| NCT00003878 ↗ | Carmustine Implants in Treating Patients With Brain Metastases | Completed | National Cancer Institute (NCI) | Phase 2 | 2002-04-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in treating patients who have brain metastases and who are undergoing surgery to remove the tumor. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GLIADEL
Condition Name
Clinical Trial Locations for GLIADEL
Trials by Country
Clinical Trial Progress for GLIADEL
Clinical Trial Phase
Clinical Trial Sponsors for GLIADEL
Sponsor Name
